SciELO - Scientific Electronic Library Online

 
vol.37 número1Characterization of clinical isolates of Mycobacterium tuberculosis from HIV positive individuals in Colombia, 2012Cross-cultural adaptation of the community-acquired pneumonia score questionnaire in patients with mild-to-moderate pneumonia in Colombia índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Biomédica

versão impressa ISSN 0120-4157

Resumo

LLERENA, Claudia; ZABALETA, Angie; VALBUENA, Angélica  e  MURCIA, Martha. Prevalence of Mycobacterium tuberculosis resistance to quinolones and injectables in Colombia, 2012-2013. Biomédica [online]. 2017, vol.37, n.1, pp.96-103. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.v37i2.3204.

Introduction:

Tuberculosis is a health problem worldwide. The World Health Organization estimated 9.6 million new cases and 480,000 multirresistant cases for 2014. The assessment of resistance to quinolones and injectables was implemented only a few years ago, so its prevalence is not known.

Objective:

To determine the prevalence of resistance to amikacin, capreomycin and ofloxacin in cases of tuberculosis resistant to isoniazid and/or rifampin during 2012-2013.

Materials and methods:

This was a cross-sectional study of 489 isolates resistant to isoniazid and/or rifampin. We used the Bactec MGITTM technique for susceptibility tests. For analyzing the rate of resistance, we grouped cases according to the history of treatment with second line drugs.

Results:

In the 438 new cases, the drug that showed greater overall resistance was kanamycin with 7.1 % (95% CI: 4.6 to 9.6). In 51 previously treated cases, this highest resistance was 27.5 % (95% CI: 14.2 to 40.7). The overall resistance was higher in cases with a history of treatment with quinolones and injectables. We found seven cases of extremely resistant tuberculosis.

Conclusion:

This study demonstrates the presence of resistance to second line drugs in people with drug-resistant tuberculosis with and without previous treatment with quinolones and/or injectables, these latter having a higher percentage of resistance. For that reason, it is essential to perform susceptibility testing and analyze this information routinely.

Palavras-chave : Mycobacterium tuberculosis; tuberculosis, multidrug-resistant; MDR tuberculosis; extensively drug-resistant tuberculosis; isoniazid; rifampin; Colombia.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )